SDX-101
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SDX-101, covering 2014-05-12 to 2014-05-12. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of SDX-101 (R-Etodolac) in Patients With Relapsed or Refractory Multiple Myeloma (MM) [Phase 2]